Thursday, December 1, 2016

Parkinsons Disease Therapeutics in Major Developed Markets to 2021 | Now Available at Researchmoz.us


Parkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia nigra region of the brain. The global Parkinson's Disease (PD) prevalence was estimated at 16.1 million in 2011, and after Alzheimer's disease it is the second most common neurodegenerative disease worldwide. To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=668356
http://www.researchmoz.us/parkinsons-disease-therapeutics-in-major-developed-markets-to-2021-early-pipeline-shifts-towards-diseasemodifying-therapies-while-short-term-growth-driven-by-longacting-symptomatic-treatments-report.html

No comments:

Post a Comment